ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

 News | News By Subject | News By Date | Search News

Clinical News Articles on Industry Topics

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
 Featured Stories
Parkinson's Disease Myth Debunked, University of Copenhagen Study     9/17/2014
American Waistlines Continues To Expand At Alarming Rate, Centers for Disease Control and Prevention (CDC) Reveals     9/17/2014
Failing Students Saved By Stress-Detecting App, Dartmouth College Study     9/17/2014
Human Faces Are Evolved To Look Unique, University of California, Berkeley (CAL) Study     9/17/2014
Aggressive People React Differently To Media Violence, Mount Sinai School of Medicine Study     9/17/2014
How You Pick Romantic Partners Could Be A Matter Of Tiny Words, University of Texas Study     9/17/2014
Cardiorespiratory Fitness Slashes High Blood Pressure Hikes In Men, University of South Carolina Study     9/17/2014
Schizophrenia Is Actually Eight Different Diseases, Washington University in St. Louis Study     9/16/2014
 More News
Jaguar Animal Health, Inc. Files Eighth Investigational New Animal Drug Application     9/17/2014
Achaogen (AKAO) Announces First Patient Enrollment In A Phase 3 Clinical Trial Of Plazomicin To Treat Infections Caused By Carbapenem-Resistant Enterobacteriaceae (CRE)     9/17/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback On ICT-107 Supporting Advancement To Registrational Phase 3 Testing In Newly Diagnosed Glioblastoma     9/17/2014
Soligenix (SNGX) Announces FDA Clearance Of Phase 3 Clinical Protocol Of SGX301 In Cutaneous T-Cell Lymphoma     9/17/2014
Merck & Co. (MRK) Presents First Phase 3 Data In Japanese Patients For Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes     9/17/2014
Janssen-Cilag International NV (JNJ) Release: Analysis Of Pooled Data From Phase 3 Trial Results Show Glycaemic Efficacy Of INVOKANA® (Canagliflozin) Is Largely Independent Of Beta-Cell Function And Insulin Sensitivity In The Treatment Of Type 2 Diabetes In Adults     9/17/2014
Novavax, Inc. (NVAX) Initiates Phase 2 Clinical Trial Of RSV F-Protein Nanoparticle Vaccine Candidate In Healthy Third-Trimester Pregnant Women     9/17/2014
BioBlast Pharma (ORPN) Announces Preclinical And Clinical Pharmacokinetic Results With Cabaletta, Interim Safety Results From Phase 2/3 HOPEMD Study In OPMD     9/17/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Overall And KRAS-Mutated Patient Data From U.S. Randomized Phase 2 Pancreatic Cancer Study     9/17/2014
Glenmark Pharmaceuticals's TRPA1 Antagonist 'GRC 17536' Shows Positive Data In A Proof Of Concept Study     9/17/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Successful Results For MOB-015 In A Phase II Study For The Treatment Of Onychomycosis     9/17/2014
Amarantus BioSciences, Inc. Provides Program Update On Phase 2b Eltoprazine For Parkinson's Disease And Adult ADHD     9/17/2014
Concert Pharmaceuticals, Inc. (CNCE) Announces Initiation Of CTP-730 Phase 1 Clinical Trial Under Celgene (CELG) Collaboration     9/17/2014
Janssen-Cilag International NV (JNJ) Release: Results From Head-To-Head Studies Of INVOKANA® (Canagliflozin) Versus JANUVIA (Sitagliptin) Highlight The Importance Of Weight-Change On Quality Of Life And Cost Effectiveness Of Canagliflozin Among People With Type 2 Diabetes     9/17/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations     9/17/2014
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Demonstrates The Safety And Efficacy Of Opregen® In Preclinical Animal Studies     9/17/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV     9/17/2014
Rox Medical Inc. Presents Positive Data For CONTROL-HTN Resistant Hypertension Trial     9/17/2014
St. Jude Children's Research Hospital Release: Improved Risk Identification Will Aid Fertility Preservation In Young Male Cancer Patients     9/17/2014
New Product From Vireo Systems: pH-D Feminine Health Support     9/17/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $4 Million From Achaogen (AKAO) For The Initiation Of A Phase 3 Study Of Plazomicin     9/17/2014
Can-Fite BioPharma (CFBI)'s Drug CF101 Is Presented In Scientific Journal As One Of Four Small Molecule Drugs For The Treatment Of Psoriasis     9/17/2014
Neuraltus Pharmaceuticals, Inc.' ALS Treatment Candidate, NP001, Highlighted At ALS Research Group Summit     9/17/2014
Intarcia Therapeutics, Inc. Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies     9/17/2014
Exco Intouch Presents At HealthXL Event In San Francisco To Drive Innovation In mHealth Solution 17-19 September 2014     9/17/2014
 Career Tips
How Biotechs Are Focusing On Employee Retention     9/22/2014
Pfizer (PFE) And Merck & Co. (MRK) Execs Exclusive: Inside Tips For Getting Hired     9/16/2014
6 Job Interview Blunders To Avoid     9/11/2014
What You MUST Ask Before You Leave The Interview     9/11/2014
Repairing Your Cover Letter And Resume After Getting Fired     9/11/2014
10 Types Of Positive And Negative Networkers     9/11/2014
How To Craft An Attention-Getting Resume     9/11/2014
Biotech Hiring Surge: Trends To Watch; Industry Tips From Arena Pharmaceuticals, Inc. (ARNA)     8/26/2014
Best Biotech Employers In America     8/26/2014
4 Untrue Things Biotech Employers May Tell Candidates     8/21/2014
Top 31 Common Interview Questions And Answers     8/21/2014
6 Tips To Ace Your Next Phone Interview     8/21/2014
How NOT To Write Your Resume     8/21/2014
Cover Letters For The Overqualified: How To Get Your Foot In The Door     8/21/2014
7 Reasons Why Recruiters And Employers Dread Reading A Resume     8/21/2014
 Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com

 
    

//-->